March: Stockholm - Utrecht - Leiden - Zurich - Paris
Join CrownBio during our European Seminar Series this March. Each interactive Seminar will focus on advancing oncology drug discovery through the use of patient-derived xenograft (PDX) models, both in Mouse Clinical Trials and with humanised mice.
We will also take time to discuss the innovative immuno-oncology platforms which CrownBio has developed to assist progression of candidate compounds.
Learn More and Network with Peers
Improved preclinical methods are required to predict response to oncology agents, and reduce overly high clinical trial attrition rates. Patient-derived xenografts (PDX) provide a model which closely recapitulates human disease, and which can be used in Mouse Clinical Trials to predict responders before you enter the clinic. Combining PDX with humanised mice also makes this translational platform highly relevant for progressing immuno-oncology agents.
Our relaxed event provides a chance to ask any oncology and immuno-oncology questions related to your studies and network with peers, as well as watch a presentation from Dr. Ludovic Bourré, Director of Scientific Engagement.
Each Seminar will include a 1 hour presentation ‘Mouse Clinical Trials and Humanised PDX to Advance Oncology Drug Discovery’, with ample time available for networking and Q&A accompanied by refreshments.
Schedule of Events
|6th March||10:00||Stockholm||SE||Freys Hotel Lilla Rådmannen, Rådmansgatan 67-69, 113 60 Stockholm|
|7th March||09:00||Leiden||NL||Cafe De Stal, Darwinweg 1, Leiden|
|7th March||14:00||Utrecht||NL||Yalelaan 40, 3584 CM Utrecht|
|8th March||11:00||Zurich||CH||Wiesenstrasse 5, Schlieren|
|9th March||09:30||Paris||FR||Mercure Paris Bercy Bibliotheque, 6 boulevard Vincent Auriol, 75013 Paris|
Register now to reserve your place at these unique events.